NBIX (Neurocrine Biosciences Inc.) Technical Analysis

NBIX Technical Analysis leverages historical price and volume data to provide real-time indicator values and signals, including RSI, MACD, Bollinger Bands, and volume, to reflect market momentum, volatility ranges, and price-volume dynamics. It also integrates market sentiment metrics such as the VIX volatility index, Advance-Decline ratio (A/D ratio), and Put/Call options ratio for broader market context. Multi-timeframe views span from minute intervals to daily, weekly, and monthly charts, making it easy to track indicator behavior across periods. Key support and resistance levels are displayed alongside current prices, calculated via pivots, Fibonacci retracements, and historical extremes to offer an immediate overview of market structure.
NBIX
NBIX

Neurocrine Biosciences Inc.

$167.76-0.21%
Today's High$168.96
Today's Low$165.70
Today's Open$168.52
Yesterday's Close$168.12

NBIX (Neurocrine Biosciences Inc.) Technical Analysis Overview

AI CreationAs of June 30, 2026, Neurocrine Biosciences Inc. (NBIX) is showing bullish technical momentum within an established uptrend structure. The MACD level at 3.8813 carries a Buy signal, confirming continued upside momentum, while the RSI(14) reading of 65.1651 sits in the strong zone (55–70), indicating sustained buyer control without overbought extremes. The moving average system exhibits textbook bullish alignment, with the EMA10 at 165.3119 and SMA20 at 162.8833 trading closely together above the EMA50 at 154.6574 and SMA200 at 142.072, reinforcing a multi-timeframe uptrend. The **NBIX technical analysis** suggests price consolidation within an established uptrend, with strong structural support and momentum signals aligned toward continued strength.

Oscillators

Strong Sell
Strong Buy
Neutral
1
Sell
8
Neutral
2
Buy

Summary

Strong Sell
Strong Buy
Buy
2
Sell
9
Neutral
15
Buy

Moving Averages

Strong Sell
Strong Buy
Strong Buy
1
Sell
1
Neutral
13
Buy

NBIX (Neurocrine Biosciences Inc.) Live Candlestick Chart

NBIX (Neurocrine Biosciences Inc.) Multi-Timeframe Technical Rating

Summary1H4H1D1W
Moving Averages (15)68113131140
Oscillators (11)NeutralNeutralNeutralNeutral
RSI (14)44.655.759.265.8
MACD (12,26)Golden CrossGolden CrossGolden CrossGolden Cross

NBIX (Neurocrine Biosciences Inc.) Technical Indicator Interpretation

Based on 1-day closing price series

Oscillators

NameValueOperation
RSI(14)
59.201Neutral
Stochastic %K (14, 3, 3)
80.8619Sell
Commodity Channel Index (CCI) (20)
86.4848Neutral
Average Directional Index (ADX) (14)
35.848Neutral
Awesome Oscillator (AO)
7.0469Neutral
Momentum Indicator (10)
10.18Buy
MACD Level (12, 26)
3.6716Buy
Stochastic RSI Fast (3, 3, 14, 14)
79.7655Neutral
Williams Percent Range (%R) (14)
-30.2469Neutral
Bull Bear Power (BBP)
6.3558Neutral
Ultimate Oscillator (UO) (7, 14, 28)
47.2975Neutral

Moving Averages

NameValueOperation
EMA (10)
165.3646Buy
SMA (10)
164.4245Buy
EMA (20)
162.7681Buy
SMA (20)
163.4103Buy
EMA (30)
160.0469Buy
SMA (30)
161.0508Buy
EMA (50)
155.0798Buy
SMA (50)
153.2403Buy
EMA (100)
148.0515Buy
SMA (100)
141.9389Buy
EMA (200)
142.3041Buy
SMA (200)
142.244Buy
Ichimoku Kinko Hyo Base Line (9, 26, 52, 26)
162.7775Neutral
Volume-Weighted Moving Average (VWMA) (20)
163.3809Buy
Hull Moving Average (HMA) (9)
170.1788Sell

NBIX (Neurocrine Biosciences Inc.) Pivot Points

Based on 1-day timeframe

PriceClassicFibonacciCamarillaWoodieDM
R3199.5867182.1417173.3324195.6675-
R2182.1417175.4777171.7333183.5838-
R1175.3383171.3607170.1341178.2225178.74
Pivot P164.6967164.6967164.6967166.1388166.3975
S1157.8933158.0327166.9359160.7775161.295
S2147.2517153.9157165.3368148.6938-
S3129.8067147.2517163.7376143.3325-

NBIX (Neurocrine Biosciences Inc.) Market Sentiment Index

Analyst Rating195.0589
Options Put/Call Ratio+44.44%
Implied Volatility (IV)47.429

NBIX (Neurocrine Biosciences Inc.) Deep Technical Analysis

As of June 30, 2026, Neurocrine Biosciences Inc. (NBIX) is exhibiting a bullish technical structure with aligned momentum signals. The MACD level stands at 3.8813 with a Buy signal, indicating that upside momentum remains intact and constructive; the RSI(14) at 65.1651 occupies the strong zone (55–70), confirming that buyers maintain control without the stock reaching overbought extremes, and price action reflects balanced accumulation. This **NBIX technical analysis** reveals structural support combined with positive momentum confirmation. The Average Directional Index (ADX) at 36.0531 signals moderate-to-strong trend strength, implying that directional persistence is well-established; this reading, combined with the Commodity Channel Index (CCI) at 149.1227 showing elevated positive momentum despite its Sell signal, suggests that the current uptrend possesses both structural conviction and short-term acceleration. The Momentum(10) reading of 10.245 with a Buy signal indicates that price velocity remains positive and supportive of further advances. The moving average system confirms a robust bullish structural setup, with the EMA10 at 165.3119 and SMA20 at 162.8833 trading in tight alignment above current price, while the EMA50 at 154.6574 and SMA200 at 142.072 provide layered support beneath. This arrangement—short-term averages elevated above intermediate and long-term averages—is textbook bullish alignment and reinforces the NBIX market analysis as positioned firmly within an uptrend; the tight clustering of the 10 and 20-period averages suggests consolidation within the broader uptrend rather than imminent acceleration. In terms of key levels, the Fibonacci retracement structure places resistance targets at R1 (162.6099), R2 (170.2876), and R3 (182.715), while support levels sit at S1 (137.7551), S2 (130.0774), and S3 (117.65). The current price of 169.64 trades above the R1 Fibonacci level, indicating that the near-term NBIX price forecast has cleared initial resistance; however, the R2 level at 170.2876 represents the next significant barrier, and a pullback would find initial support around the R1 level at 162.6099. On the market breadth front, the analyst rating aggregate at 195.0589 reflects overall positive sentiment from the research community, while the implied volatility at 46.362 suggests elevated option-market pricing consistent with heightened uncertainty. The Put/Call ratio at 5.63 indicates meaningful hedging demand, a sign that market participants are maintaining defensive positioning despite the bullish moving average alignment; this divergence between structural bullish setup and elevated protective demand suggests the NBIX price prediction remains contingent on whether momentum can sustain and break through the 170.2876 resistance level decisively.

FAQ

What is the current technical rating for NBIX?

x
On the 4H timeframe, the aggregate technical rating for NBIX is Buy. This rating is dynamically aggregated from moving averages and momentum oscillators to reflect the prevailing trend direction and price velocity.

Where are the key support and resistance levels for NBIX?

x

What are the current RSI and MACD signals for NBIX?

x

How often is the NBIX technical analysis data updated?

x

Continue Exploring NBIX (Neurocrine Biosciences Inc.)

Risk Warning:

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Warning.

Disclaimer:

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.